Pediatric Neurosurgery, University of Central Florida College of Medicine, Orlando , Florida , USA.
Department of Neurological Surgery, Indiana University Health, Indianapolis , Indiana , USA.
Neurosurgery. 2023 Oct 1;93(4):731-735. doi: 10.1227/neu.0000000000002635. Epub 2023 Aug 30.
Chiari malformation type I (CIM) diagnoses have increased in recent years. Controversy regarding the best operative management prompted a review of the literature to offer guidance on surgical interventions.
To assess the literature to determine (1) whether posterior fossa decompression or posterior fossa decompression with duraplasty is more effective in preoperative symptom resolution; (2) whether there is benefit from cerebellar tonsillar resection/reduction; (3) the role of intraoperative neuromonitoring; (4) in patients with a syrinx, how long should a syrinx be observed for improvement before additional surgery is performed; and 5) what is the optimal duration of follow-up care after preoperative symptom resolution.
A systematic review was performed using the National Library of Medicine/PubMed and Embase databases for studies on CIM in children and adults. The most appropriate surgical interventions, the use of neuromonitoring, and clinical improvement during follow-up were reviewed for studies published between 1946 and January 23, 2021.
A total of 80 studies met inclusion criteria. Posterior fossa decompression with or without duraplasty or cerebellar tonsil reduction all appeared to show some benefit for symptom relief and syrinx reduction. There was insufficient evidence to determine whether duraplasty or cerebellar tonsil reduction was needed for specific patient groups. There was no strong correlation between symptom relief and syringomyelia resolution. Many surgeons follow patients for 6-12 months before considering reoperation for persistent syringomyelia. No benefit or harm was seen with the use of neuromonitoring.
This evidence-based clinical guidelines for the treatment of CIM provide 1 Class II and 4 Class III recommendations. In patients with CIM with or without syringomyelia, treatment options include bone decompression with or without duraplasty or cerebellar tonsil reduction. Improved syrinx resolution may potentially be seen with dural patch grafting. Symptom resolution and syrinx resolution did not correlate directly. Reoperation for a persistent syrinx was potentially beneficial if the syrinx had not improved 6 to 12 months after the initial operation. The full guidelines can be seen online at https://www.cns.org/guidelines/browse-guidelines-detail/3-surgical-interventions .
近年来,Chiari 畸形 I 型(CIM)的诊断有所增加。关于最佳手术治疗方法的争议促使我们对文献进行回顾,以提供手术干预的指导。
评估文献以确定:(1)后颅窝减压与硬脑膜成形术相比,在术前症状缓解方面更有效;(2)小脑扁桃体切除术/切除术是否有益;(3)术中神经监测的作用;(4)对于存在脊髓空洞症的患者,在进行额外手术之前,应该观察多长时间脊髓空洞症以改善;以及(5)在术前症状缓解后,进行最佳的随访护理时间。
使用美国国立医学图书馆/PubMed 和 Embase 数据库对 1946 年至 2021 年 1 月 23 日期间发表的关于儿童和成人 CIM 的研究进行了系统评价。回顾了最合适的手术干预措施、神经监测的使用以及在随访期间的临床改善情况。
共有 80 项研究符合纳入标准。后颅窝减压联合或不联合硬脑膜成形术或小脑扁桃体切除术/切除术似乎都对缓解症状和缩小脊髓空洞症有一定的益处。没有足够的证据来确定特定患者群体是否需要硬脑膜成形术或小脑扁桃体切除术/切除术。症状缓解与脊髓空洞症缓解之间没有很强的相关性。许多外科医生在考虑对持续存在的脊髓空洞症进行再次手术之前,会让患者随访 6-12 个月。使用神经监测没有带来好处或危害。
本循证临床指南为 CIM 的治疗提供了 1 项 II 级和 4 项 III 级推荐。对于伴有或不伴有脊髓空洞症的 CIM 患者,治疗选择包括骨减压联合或不联合硬脑膜成形术或小脑扁桃体切除术/切除术。硬脑膜修补术可能会潜在地改善脊髓空洞症的缓解。症状缓解和脊髓空洞症缓解之间没有直接的相关性。如果初始手术后 6 至 12 个月脊髓空洞症没有改善,再次手术对持续存在的脊髓空洞症可能有益。完整的指南可以在网上 https://www.cns.org/guidelines/browse-guidelines-detail/3-surgical-interventions 查看。